Simcere Pharma (SCR) Tops Q3 Views; EPS Beats by 1c

Article Stock Quotes (1) Comments (0)

Simcere Pharmaceutical Group. (NYSE: SCR) reports Q3 EPS of $0.08, 1 cent better than the analyst estimate of $0.07. Revenue for the quarter came in at $82.2 million, versus the consensus estimate of $76.18 million.

---

Join StreetInsider.com FREE and get immediately alerted when news breaks on your stocks and other market items - JOIN NOW

---

*NEW - Download StreetInsider's FREE iPhone and iPad App - Click Here

---

---

You May Also Be Interested In

• Best Buy (BBY) Posts Q1 adj.-EPS of 32c; Comps Down 1.1%
• TJX Cos. (TJX) Reports In-Line Q1 EPS; Guides Q2 EPS, Narrows FY14 Outlook
• MGT Capital (MGT) Posts Q1 EPS of $0.24

Create E-mail Alert Related Categories

Earnings

Add Your Comment

Name

Subject

Body

Share on Facebook

Verification
can't see the text?
click here to refresh the image.
what's this?